Moderated by industry experts, you can now join your fellow attendees in interactive roundtable sessions running throughout the entire event.
See the topics here
2019 is the year for innovation! This has been echoed by leading pharma companies, the government, as well as leading associations like the FPMAJ, JPMA and JPWA.
Join 450+ pharma decision makers from Sales, Marketing, Digital, Business Development, Medical Affairs, Market Access and RWE related functions as they meet in Tokyo, May 22-23. Cutting-edge solution providers will join them to write the blueprint for healthcare’s future, guided by our outstanding speaker faculty.
To deliver new medicines to patients while securing long-term growth, pharma needs to know what organisational reform and initiatives will be effective to decide what form innovation will take.
eyeforpharma Japan is where senior-level pharma leaders find answers. This is where we share and explore inspirational, practical solutions. We begin with plenary sessions from keynote (C-level/President/SVP/VP/Government) speakers who set out the vision of Japanese healthcare. The conference then splits, with an entire track dedicated to practical Commercial Excellence – and a second track dedicated to the increasingly pivotal topic of Real-World Evidence.
Thorsten PoehlPresident and Representative DirectorBoehringer Ingelheim Japan, Inc. (BIJI)
Satoru NoguchiPresidentCelgene K.K.
Jason HoffePresident and Representative DirectorSandoz K.K.
Alexandre de MuraltRepresentative Director and PresidentMerck Serono Co., Ltd
Stefan SakuraiPresident, Japan Representative DirectorLEO Pharma K.K.
Kotonari AokiDepartment Manager, Real World Data Science Dept.Chugai Pharmaceutical Co.,Ltd.
Motoi MurakiHead of Market Access & Business Development OncologyNovartis
Daniel Junichiro RuzickaExecutive Director, Medical AffairsMSD K.K.
Tomoo MiyakeDirector Business Excellence & OperationsGilead Sciences K.K.
Koji KawakamiProfessor and Chair, Graduate School of Medicine and Public HealthKyoto University